Antiplatelet therapy for thromboprophylaxis: the need for careful consideration of the evidence from randomised trials (original) (raw)

This paper critiques the current evidence surrounding antiplatelet therapy for thromboprophylaxis, highlighting its importance in preventing serious vascular events, particularly in high-risk patients. It discusses various studies and meta-analyses, emphasizing the need for careful consideration of trial results when making treatment recommendations. The findings suggest that antiplatelet therapy may be beneficial, either alone or in combination with other prophylactic methods, until further data from larger trials are available.